MedDataX Logo

ECT Schizophrenia Serotonin Study

NCT ID: NCT00278668

Last Updated: 2008-05-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

15 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-10-31

Study Completion Date

2006-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Schizophrenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995).

Ages 18 -55 Men and/or women -

Exclusion Criteria

1. History of neurological disorders, active substance abuse in the previous 3 months.
2. Estimated IQ less then 70.
3. SSRIs treatment 4 weeks prior to the study.
4. Any subject suffering from inflammatory fever disease will be excluded from the study.

\-
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sha'ar Menashe Mental Health Center

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Avi Peled, MD

Role: PRINCIPAL_INVESTIGATOR

Shaar Menashe MHC

Ilan Modai, M.D. MHA

Role: PRINCIPAL_INVESTIGATOR

Shaar Menashe

Moshe Rehavi, Ph.D.

Role: PRINCIPAL_INVESTIGATOR

TAU

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Avi Peled, MD

Role: CONTACT

Phone: 972522844050

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

123.ctil

Identifier Type: -

Identifier Source: org_study_id